Two New Faces of Molecular Time: How Cells Keep More Clocks Than We Knew
The body keeps time in more ways than we once imagined. Circadian rhythms, the ~24-hour cycles driven by the PERIOD protein, are the most familiar biological clock. But two papers published in June 2026 reveal very different kinds of molecular timekeeping operating at entirely different scales — one orchestrating the sequential stages of development in a microscopic worm, the other setting the pace of neurodegeneration in the human brain.
One is a clock that counts forward, never repeats, and stops after exactly four ticks. The other is a metabolic timer running on sugar — and when it runs too fast, it may accelerate Alzheimer’s disease.
The developmental ratchet
In the roundworm Caenorhabditis elegans, development proceeds through four precisely timed larval stages. For decades, researchers knew that pulses of gene expression drove each transition, but what controlled the timing of those pulses remained unknown.
A team at Cold Spring Harbor Laboratory, publishing in Proceedings of the National Academy of Sciences, has now identified the mechanism. It is a two-protein circuit — MYRF-1 and LIN-42 — that acts as a finite-sequence molecular clock: a non-repeating, ratchet-like timer that counts exactly four pulses and then stops.
“This is the central clock for all cells in the worm,” said Christopher Hammell, the corresponding author. “It’s responsible for coordinating a finite series of sequential pulses of gene expression that must occur only once, and in order, for proper developmental progression. It’s like a ratchet.”
The mechanism works as follows. MYRF-1 is a transmembrane transcription factor that, upon cleavage, enters the nucleus and drives synchronized pulses of gene expression across all somatic tissues. Among the genes it activates is the heterochronic microRNA lin-4, a master regulator of developmental timing whose discovery earned the 2024 Nobel Prize.
At the same time, MYRF-1 activates lin-42 — the C. elegans version of the circadian protein PERIOD. Newly synthesized LIN-42 then binds directly to MYRF-1, limiting its nuclear activity and constraining the amplitude and duration of each pulse. The result is a precisely timed, self-limiting burst of gene expression that can only move forward.
Each pulse licenses a developmental checkpoint essential for growth and molting. Block MYRF-1 entirely, and development stops.
The finding is the first documented example of a non-repeating biological clock. Circadian clocks cycle indefinitely. The MYRF-1/LIN-42 clock ticks exactly four times in a worm’s lifetime.
The team used AlphaFold, the AI protein structure prediction tool, to model the physical interaction between MYRF-1 and LIN-42, alongside yeast two-hybrid assays and traditional molecular biology. The structural insight was key to understanding the feedback mechanism.
Hammell noted an open question: every cell in the worm appears to run this clock in synchrony, but how they stay coordinated is unknown. “Are they communicating with each other? We’ve never thought deeply about that question before.”
The sugar timer in Alzheimer’s
A separate study, published in Nature Metabolism on June 9 by a large collaborative team led by the University of Florida, identifies a very different kind of molecular timer — one that ticks in metabolism rather than development, and whose dysregulation may accelerate the deadliest neurodegenerative disease.
The finding begins with a surprising observation. Glucosamine, an over-the-counter joint supplement taken by roughly 40 million Americans, was associated with worse outcomes in people with mild cognitive impairment and Alzheimer’s disease. Analyzing electronic health records from 65,000 patients at UF Health spanning 2012 to 2024, the researchers found that glucosamine users were 25% more likely to progress from mild cognitive impairment to dementia (p<0.001) and 25% more likely to die within ten years of an Alzheimer's diagnosis (p=0.0023).
But the study’s importance goes well beyond the glucosamine finding. What the team discovered is a fundamental metabolic mechanism: hyperglycosylation — the excessive attachment of sugar molecules to proteins — as a driver of Alzheimer’s pathology.
In postmortem Alzheimer’s brain tissue, the researchers found that N-glycan accumulation scales with Braak stage, the pathological staging system for the disease. Using spatial isotopic tracing, they showed that this excess sugar came from increased glycan biosynthesis, not impaired clearance. In transgenic mouse models of Alzheimer’s, oral glucosamine supplementation worsened social recognition memory, while genetically knocking down glycan-producing enzymes improved cognitive outcomes.
The connection is the hexosamine biosynthetic pathway. Glucosamine feeds into this pathway, producing UDP-GlcNAc, the substrate for N-linked glycosylation. In an already-diseased brain, this accelerates a process that is already running too fast.
“This paper shows very clearly that hyperglycosylation is not a bystander in Alzheimer’s disease — it is a metabolic driver,” said Ramon C. Sun, the senior author.
An important nuance emerged from the data. The harmful effect appears specific to brains that have already begun neurodegeneration. Healthy mice given glucosamine showed no effects. Earlier Mendelian randomization studies had even suggested glucosamine might be protective against dementia in cognitively normal adults. The picture that emerges is a metabolic timer that, once the brain crosses a certain threshold, accelerates the disease.
“No CNS-penetrant N-glycan inhibitors exist yet for human testing,” the authors noted, though several exist in cancer research. A commentary by Yasuhiko Kizuka of Gifu University, published alongside the paper, called for a clinical trial.
The broader picture of biological timekeeping
Taken together, the two studies illustrate how far the concept of biological timekeeping extends beyond the familiar circadian cycle. The MYRF-1/LIN-42 clock runs once, forward, and stops — a finite counter for development. The O-GlcNAc/hyperglycosylation axis runs as a metabolic rheostat that, when disrupted, accelerates neurodegeneration.
Both mechanisms use proteins that were known for other functions. MYRF-1 was recognized as a membrane-bound transcription factor involved in synaptic rewiring. LIN-42 was known as a circadian homolog. Glucosamine was thought of as a harmless supplement. The discoveries come from seeing familiar molecules through a new lens — one focused on how cells measure time.
Whether the MYRF-1-LIN-42 circuit has a human analog remains unknown — the MYRF gene family is conserved in vertebrates, but no one has yet looked for a similar developmental timer. The question Hammell posed for worms — do the clocks in individual cells communicate? — may someday be asked for human cells as well.
Sources
Wu P, Wang J, Pryor B, et al. A molecular timer couples organism-wide temporal identity to developmental checkpoints. Proceedings of the National Academy of Sciences. 2026;123(19):e2606846123. DOI: 10.1073/pnas.2606846123
Hawkinson TR, Liu Z, Ribas RA, et al. Hyperglycosylation is a metabolic driver of Alzheimer’s disease. Nature Metabolism. 2026. DOI: 10.1038/s42255-026-01538-4